[1] |
Sun ZH, Yu SY, Liu YJ, et al. Comparion of randomized controlled clinical trial on concurrent chemotherapy plus radiotherapy in locally advanced non small cell lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2005, 8(6): 547-9. [孙志华, 于世英, 刘英杰, 等. 局部晚 期非小细胞肺癌同步放化疗随机对照临床试验[J]. 中国肺癌杂 志, 2005, 8(6): 547-9.]
|
[2] |
Duffaud F, Therasse P. New guidelines to evaluate the response to treatment in solid tumors[J]. Bull Cancer, 2000, 87(12): 881-6.
|
[3] |
Chen K, Piao YR, Xie GM, et al. Clinical comparition of curative effect on concurrent chemoradiation plus chemotherapy and sequential chemoradiation in the treatment of elderly stage Ⅲ non-small cell lung cancer[J]. Zhongguo Lao Nian Xue Za Zhi, 20 14, 9: 2420-1. [陈科, 朴勇瑞, 谢国明, 等. 同步放化疗加巩固 化疗与序贯放化疗治疗老年Ⅲ期非小细胞肺癌的疗效对比[J]. 中国老年学杂志, 2014, 9: 2420-1.]
|
[4] |
Hu HT, Gong CM, Zeng LJ, et al. Clinical observation on concurrent chemotherapy plus radiotherapy in treatment of stage Ⅲnon-small cell lung cancer[J]. Ju Jie Shou Shu Xue Za Zhi, 20 11, 20(1): 74-5. [胡海涛, 龚传明, 曾丽娟, 等. 同步放化疗 治疗Ⅲ期非小细胞肺癌的近期疗效观察[J]. 局解手术学杂志, 20 11, 20(1): 74-5.]
|
[5] |
Wang CL, Zhu JQ. Progress in the treatment of lung cancer surgery [J] Zhongguo Zhong Liu Lin Chuang, 2011, 38(24): 1479-83. [王长利, 朱建权. 肺癌外科治疗研究进展[J]. 中国肿瘤临床, 2011, 38 (24): 1479-83.]
|
[6] |
Wang CL, Yue DS, Zhang ZF, et al. Treatment and prognostic analysis of 1638 patients with non-small cell lung cancer [J]. Zhonghua Wai Ke Za Zhi, 2011, 49(7): 618-22. [王长利, 岳东升, 张真发, 等. 非小细胞肺癌1638例治疗及预后探讨[J]. 中华外科 杂志, 2011, 49(7): 618-22.]
|
[7] |
Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials[J]. BMJ, 19 95, 311(7010): 899-909.
|
[8] |
ArriagadaR, BergmanB, DunantA, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-smallcell lung cancer[J]. N Engl J Med, 2004, 350(4): 351-60.
|
[9] |
Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stageⅠB-ⅢA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial[J]. Lancet Oncol, 2006, 7(9): 719-27.
|
[10] |
Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer[J]. N Engl J Med, 2005, 352(25): 2589-97.
|
[11] |
Pignon JP, Tribodet H, Scagliotti GV, et al. LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group[J]. J Clin Oncol, 2008, 26(21): 35 52-9.
|
[12] |
Leong SS, Fong KW, Lim WT, et al. A phase Ⅱ trial of induction gemcitabine and vinorelbine followed by concurren t vinorelbine and radiotherapy in locally advanced non-small cell lung cancer[J]. Lung Cancer, 2010, 67(3): 325-9.
|
[13] |
Chen BY, Fang ZY, Liu DG, et al. Clinical observation of GP chemotherapy sequential 3D-CRT for elderly locally advanced non small cell lung cancer[J]. Xian Dai Zhong Liu Yi Xue, 2013, 8( 21): 1781-3. [陈宝玉, 房振羽, 刘德干, 等. GP方案序贯三维 适形放疗治疗老年局部晚期非小细胞肺癌疗效观察[J]. 现代肿 瘤医学, 2013, 21(8): 1781-3.]
|
[14] |
Zheng QW, Zheng L, Chen WQ. Comparative study on Concurrent chemoradiation and sequential chemoradiation in treatment of stage Ⅲ non-small cell lung cancer[J]. Zhongguo Shi Yong Yi Yao, 2013, 8(27): 126-7. [郑庆伟, 郑灵, 陈万泉. Ⅲ期非小细 胞肺癌同步与序贯放化疗对比研究[J]. 中国实用医药, 2013, 8( 27): 126-7.]
|